| |
N (%)
|
AUS
|
DEN
|
NLD
|
RUS
|
|---|
|
n (%)
|
|---|
|
Cases
|
1620 (100)
|
643 (39.7)
|
774 (47.8)
|
101 (6.2)
|
102 (6.3)
|
|
Males
|
902 (55.7)
|
367 (57.1)
|
435 (56.2)
|
59 (58.4)
|
41 (40.2)a
|
|
Median age (min–max)
|
63.0 years (18.1–88.0)
|
62.6 years (18.1–85.4)
|
64.3 years (50.0–75.8)
|
62.0 years (37.0–88.0)
|
56.5 yearsa (34.0–86.0)
|
|
Cancer
|
184 (11.4)
|
27 (14.7)
|
91 (49.5)
|
17 (9.2)
|
49 (26.6)
|
|
Males
|
97 (52.7)
|
14 (51.9)
|
52 (57.1)
|
10 (58.8)
|
21 (42.9)
|
|
Median age (min–max)
|
67.2 years (35.0–88.0)
|
66.2 years (45.7–81.1)
|
68.7 years (50.1–75.2)
|
70.0 years (37.0–88.0)
|
62.0 yearsa (35.0–86.0)
|
|
Stage I
|
41 (22)
|
7 (17.1)
|
20 (48.8)
|
3 (7.3)
|
11 (26.8)
|
|
Stage II
|
57 (31)
|
9 (15.8)
|
20 (35.1)
|
7 (12.3)
|
21 (36.8)
|
|
Stage III
|
51 (28)
|
5 (9.8)
|
35 (68.6)
|
4 (7.8)
|
7 (13.7)
|
|
Stage IV
|
33 (18)
|
6 (18.2)
|
16 (48.5)
|
3 (9.1)
|
8 (24.2)
|
|
Unstaged
|
2 (1%)
|
0 (–)
|
0 (–)
|
0 (–)
|
2 (100)
|
|
Adenoma
|
616 (38.0)
|
332 (53.9)
|
197 (32.0)
|
52 (8.4)
|
35 (5.7)
|
|
Males
|
387 (62.8)
|
207 (62.3)
|
131 (66.5)
|
33 (63.5)
|
16 (45.7)a
|
|
Median age (min–max)
|
63.5 years (33.7–85.4)
|
64.1 years (33.7–85.4)
|
64.1 years (50.0–75.8)
|
62.4 years (51.0–75.0)
|
56.1 yearsa (34.0–82.0)
|
|
Advanced
|
337 (54.7)
|
147 (44.3)
|
149 (75.6)
|
38 (73.1)
|
3 (8.6)
|
|
Non-advanced
|
279 (45.3)
|
185 (55.7)
|
48 (24.4)
|
14 (26.9)
|
32 (91.4)
|
|
HGDb
|
35 (5.7)
|
15 (4.5)
|
18 (9.1)
|
2 (3.8)
|
0 (0)
|
|
LGDb
|
549 (89.1)
|
317 (95.5)
|
179 (90.9)
|
18 (34.6)
|
35 (100)
|
|
No neoplasia
|
820 (50.6%)
|
284 (34.6)
|
486 (59.3)
|
32 (3.9)
|
18 (2.2)
|
|
Males
|
418 (51.0)
|
146 (51.4)
|
252 (51.9)
|
16 (50.0)
|
4 (22.2)a
|
|
Median age (min–max)
|
60.0 years (18.0–85.0)
|
56.7 years (18.0–85.0)
|
62.2 years (50.0–75.0)
|
61.6 years (52.0–75.0)
|
47.5 yearsa (36.0–59.0)
|
- AUS, Flinders Medical Centre, Australia; DEN, Hvidovre Hospital, Denmark; NLD, Amsterdam University Medical Centers or Flevo Hospital, The Netherlands; RUS, Proteogenex
- aChi square, collection site significantly different from the other sites
- bThe severity of dysplasia was available for 584 of 616 adenomas. HGD high grade dysplasia, LGD low grade dysplasia
